Compliance and Risk Management
Promoting Compliance and Risk Management
We believe that compliance and risk management are the two inseparable pillars of internal control. They form the basis for sound corporate governance and are a focus of our CSR activities. We are working hard to ensure that corporate ethics are strictly upheld at all group companies and to promote business continuity management (BCM).
Code of Conduct
We act with integrity in compliance with laws and regulations, and show respect for human rights and local communities in which we operate.
Compliance and Risk Management (CRM) Promotion System
The Group CRM Subcommittee, established under the Group CSR Committee, meets twice a year to deliberate on CRM-related policies, measures and activities, and promote their group-wide expansion.
In Japan, at business groups and group companies, we have appointed a person in charge of promoting CRM who manages/operates activities at respective workplaces. Overseas, each business group and group company conducts its own independent training, and global compliance meetings organized by Teijin Limited are held in main overseas regions every year. In FY2016, we held a total of five meetings, with three in Thailand and two in the U.S.
Positioning of Compliance and Risk Management
PDCA cycle of compliance and risk management activities
Results of Reviews by Chief Social Responsibility Officer (Law Violations and Occurrence of Accidents)
Every February, the Chief Social Responsibility Officer reviews the CRM activities for the previous calendar year of business groups and group companies. This review assesses whether there were any serious violations of laws or accidents during CRM activities, and confirms the compliance and risk management activities of business groups and group companies on the basis of the compliance and risk management activity survey submitted.
Of the matters reported to the Chief Social Responsibility Officer in February 2017, there were no serious matters relating to violations of laws or accidents. In regards to the case of having Teijin Pharma Limited complete a post-marketing survey as proxy in the previous year, which was reported as a serious matter, recurrence prevention measures such as the enforcement of employee training and reinforcement of management systems were implemented, and it was confirmed that measures to restore trustworthiness were being rolled out at a steady pace.